Endo International on Monday said it has entered into a agreement resolving all known lawsuits against it alleging injuries caused by testosterone replacement drugs, joining other drugmakers who have reached similar settlements in recent months.

The company in a statement said its subsidiaries Endo Pharmaceuticals Inc and Auxilium Pharmaceuticals, which were part of the multidistrict litigation in Chicago federal court, would make a one-time payment into a settlement fund.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2JJiljT